Phenaros Pharmaceuticals
Phenaros Pharmaceuticals is a Swedish spin-off drug discovery company from Uppsala University that accelerates drug discovery using AI, phenomics, and automation. Their platform integrates large-scale cell morphological profiling (Cell Painting) with AI-driven decision-making and robotics to perform precise experiments, reducing costs and time in drug discovery cycles. They focus on discovering and repurposing drugs for rare diseases and operate both an in-house drug discovery pipeline and partnerships providing access to their discovery platform. Their AI-first approach leverages high-quality data collected through automated experiments to enhance understanding of complex biology and improve drug discovery efficiency and safety.
Phenaros Pharmaceuticals
Phenaros Pharmaceuticals is a Swedish spin-off drug discovery company from Uppsala University that accelerates drug discovery using AI, phenomics, and automation. Their platform integrates large-scale cell morphological profiling (Cell Painting) with AI-driven decision-making and robotics to perform precise experiments, reducing costs and time in drug discovery cycles. They focus on discovering and repurposing drugs for rare diseases and operate both an in-house drug discovery pipeline and partnerships providing access to their discovery platform. Their AI-first approach leverages high-quality data collected through automated experiments to enhance understanding of complex biology and improve drug discovery efficiency and safety.